Header

UZH-Logo

Maintenance Infos

Introduction of Rivaroxaban in an Orthopaedic Department


Borgeat, A (2010). Introduction of Rivaroxaban in an Orthopaedic Department. Advances in Orthopaedics, 2(3):100-105.

Abstract

Rivaroxaban is a new antithrombotic drug that has been shown to provide superior efficacy to enoxaparin without increasing the risk of bleeding after major lower limb surgery. T he introduction of this drug in a surgical department represents a paradigm change, since rivaroxaban is not administered preoperatively but postoperatively, and is not given subcutaneously but orally.

Abstract

Rivaroxaban is a new antithrombotic drug that has been shown to provide superior efficacy to enoxaparin without increasing the risk of bleeding after major lower limb surgery. T he introduction of this drug in a surgical department represents a paradigm change, since rivaroxaban is not administered preoperatively but postoperatively, and is not given subcutaneously but orally.

Statistics

Additional indexing

Item Type:Journal Article, not refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Balgrist University Hospital, Swiss Spinal Cord Injury Center
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2010
Deposited On:21 Feb 2011 08:19
Last Modified:05 Apr 2016 14:48
Publisher:Remedica Medical Education and Publishing
ISSN:1758-8294
Related URLs:http://www.remedicajournals.com/Advances-in-Orthopaedics/Default.aspx (Publisher)

Download

Full text not available from this repository.